NCT01795248

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 105 (actual)
• Sponsor: Tina Vilsboll · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

It is well-known that women with previous gestational diabetes mellitus are in risk of developing type 2 diabetes later in life; approximately half of the women develop overt type 2 diabetes within the first 10 years after pregnancy. Knowing this, we want to examine the effect of the type 2 diabetes medicine, liraglutide (Victoza), in women with previous gestational diabetes with the aim of reducing the risk of developing type 2 diabetes.

Conditions

• Gestational Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	Liraglutide	1.8 mg liraglutide
DRUG	Placebo	Liraglutide without the GLP-1 analogue

Timeline

• Start date: 2012-07-01
• Primary completion: 2019-09-01
• Completion: 2020-09-01
• First posted: 2013-02-20
• Last updated: 2020-11-04

Locations

1 site across 1 country: Denmark